BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10507950)

  • 1. The use of stereotactically guided core needle biopsy has certainly increased the preoperative diagnostic rate and, in our experience, substantially decreased the number of benign biopsies being done.
    McCaffrey J
    World J Surg; 1999 Sep; 23(9):981. PubMed ID: 10507950
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactically guided needle biopsy of the breast for nonpalpable lesions.
    Harolds JA
    J Okla State Med Assoc; 1993 Dec; 86(12):604-12. PubMed ID: 8126588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
    Orel SG; Rosen M; Mies C; Schnall MD
    Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underestimation of malignancy of atypical ductal hyperplasia diagnosed on 11-gauge stereotactically guided Mammotome breast biopsy: an Asian breast screen experience.
    Teng-Swan Ho J; Tan PH; Hee SW; Su-Lin Wong J
    Breast; 2008 Aug; 17(4):401-6. PubMed ID: 18455920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds?
    Carmichael AR; Berresford A; Sami A; Boparai R
    Breast; 2004 Jun; 13(3):232-4. PubMed ID: 15177427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis.
    Verkooijen HM; Peeters PH; Buskens E; Koot VC; Borel Rinkes IH; Mali WP; van Vroonhoven TJ
    Br J Cancer; 2000 Mar; 82(5):1017-21. PubMed ID: 10737383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of Core Biopsy for BI-RADS-5 Breast Lesions.
    Wolf R; Quan G; Calhoun K; Soot L; Skokan L
    Breast J; 2008; 14(5):471-5. PubMed ID: 18821933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective use of breast biopsy techniques in a Veterans health care system.
    Hatmaker AR; Donahue RM; Tarpley JL; Pearson AS
    Am J Surg; 2006 Nov; 192(5):e37-41. PubMed ID: 17071179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
    Verkooijen HM; Vlastos G; Kinkel-Trugli K
    Breast Cancer Res Treat; 2005 Mar; 90(2):191. PubMed ID: 15803366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with percutaneus large-core needle biopsies of the breast and evaluation of cytopathological and histopathological results].
    Anlauf M; Nicklaus S; Rode G; Jäckel C; Neumann K; Kalbfleisch H; Mühlberger G
    Zentralbl Gynakol; 2003 Sep; 125(9):353-61. PubMed ID: 14569517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
    Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
    Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy.
    Arora N; Hill C; Hoda SA; Rosenblatt R; Pigalarga R; Tousimis EA
    Am J Surg; 2007 Oct; 194(4):444-9. PubMed ID: 17826053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotactic needle breast biopsy: Diagnostic reliability of various biopsy systems and needle sizes].
    Pfarl G; Helbich TH; Riedl CC; Rudas M; Wagner T; Memarsadeghi M; Lomoschitz F
    Rofo; 2002 May; 174(5):614-9. PubMed ID: 11997862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the pathologic diagnosis of selected unusual lesions in needle core biopsies of breast.
    Hoda SA; Rosen PP
    Breast J; 2004; 10(6):522-7. PubMed ID: 15569209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographically and stereotactically guided fine-needle aspiration cytology of non-palpable breast lesions: cyto-histological correlation.
    Pogacnik A; Strojan Flezar M; Rener M
    Cytopathology; 2008 Oct; 19(5):303-10. PubMed ID: 17944953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast biopsy utilization: a population-based study.
    Ghosh K; Melton LJ; Suman VJ; Grant CS; Sterioff S; Brandt KR; Branch C; Sellers TA; Hartmann LC
    Arch Intern Med; 2005 Jul; 165(14):1593-8. PubMed ID: 16043676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of core biopsy imprint cytology in the 'one-stop' breast clinic.
    Kulkarni D; Irvine T; Reyes RJ
    Eur J Surg Oncol; 2009 Oct; 35(10):1037-40. PubMed ID: 19268520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.
    Kumaroswamy V; Liston J; Shaaban AM
    J Clin Pathol; 2008 Jun; 61(6):766-9. PubMed ID: 18326021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.